Posted by Michael Wonder on 27 Feb 2017
US drug firms limit price hikes, but still cost health system billions
28 February 2017 - Facing mounting criticism about prices, drug companies put some limits on increases this year.
Prescription-drug makers traditionally raise list prices in January. This year, they didn’t raise prices for as many drugs as last year and imposed fewer boosts of 10% or greater, according to analysis by investment firm Raymond James & Associates.
About 5.5% of increases reached the 10% level. A year ago, 15% did, and two years ago, 20%.
